APO Research
Talk to an analyst

APO RESEARCH · REPORT

Topiramate Tablets

Compare research editions
View pricing & licenses

Selected research

Industry Research

Topiramate Tablets Industry Research Report 2026

27 December 2025131 pages

Choose your research edition.

Industry ResearchTopiramate Tablets Industry Research Report 2026131 pages · $2,950 USDIndustry Growth & TrendsGlobal Topiramate Tablets Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Topiramate Tablets Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Topiramate Tablets Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Topiramate Tablets Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Topiramate Tablets market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Topiramate Tablets is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Topiramate Tablets is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Topiramate Tablets is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Topiramate Tablets include Accord Healthcare, Ascent Pharmaceuticals, Aurobindo Pharma, Cipla, Glenmark Pharmaceuticals, Janssen Pharmaceuticals, Kyowa Pharmaceutical, Sun Pharmaceutical and Taj Pharmaceuticals, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Topiramate Tablets market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Topiramate Tablets Market by Company

Accord Healthcare

Ascent Pharmaceuticals

Aurobindo Pharma

Cipla

Glenmark Pharmaceuticals

Janssen Pharmaceuticals

Kyowa Pharmaceutical

Sun Pharmaceutical

Taj Pharmaceuticals

Teva Pharmaceuticals

Unichem Laboratories

Viwit Pharmaceuticals

Zydus Pharmaceuticals

Hefei Cosource (Heyuan) Pharmaceutical

Zhejiang Huahai Pharmaceutical

Topiramate Tablets Segment by Type

100mg per Tablet

200mg per Tablet

25mg per Tablet

50mg per Tablet

Topiramate Tablets Segment by Application

Migraine

Epilepsy

Other

Topiramate Tablets Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Topiramate Tablets market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Topiramate Tablets and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Topiramate Tablets.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Topiramate Tablets manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Topiramate Tablets by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Topiramate Tablets in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Topiramate Tablets Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Topiramate Tablets Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Topiramate Tablets Sales Market Share by Manufacturers (2021-2026) Table 8. Global Topiramate Tablets Revenue of Manufacturers (2021-2026) Table 9. Global Topiramate Tablets Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Topiramate Tablets Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Topiramate Tablets Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Topiramate Tablets, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Topiramate Tablets, Product Type & Application Table 14. Global Topiramate Tablets Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Topiramate Tablets by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Accord Healthcare Company Information Table 19. Accord Healthcare Business Overview Table 20. Accord Healthcare Topiramate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Accord Healthcare Topiramate Tablets Product Portfolio Table 22. Accord Healthcare Recent Developments Table 23. Ascent Pharmaceuticals Company Information Table 24. Ascent Pharmaceuticals Business Overview Table 25. Ascent Pharmaceuticals Topiramate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Ascent Pharmaceuticals Topiramate Tablets Product Portfolio Table 27. Ascent Pharmaceuticals Recent Developments Table 28. Aurobindo Pharma Company Information Table 29. Aurobindo Pharma Business Overview Table 30. Aurobindo Pharma Topiramate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Aurobindo Pharma Topiramate Tablets Product Portfolio Table 32. Aurobindo Pharma Recent Developments Table 33. Cipla Company Information Table 34. Cipla Business Overview Table 35. Cipla Topiramate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Cipla Topiramate Tablets Product Portfolio Table 37. Cipla Recent Developments Table 38. Glenmark Pharmaceuticals Company Information Table 39. Glenmark Pharmaceuticals Business Overview Table 40. Glenmark Pharmaceuticals Topiramate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Glenmark Pharmaceuticals Topiramate Tablets Product Portfolio Table 42. Glenmark Pharmaceuticals Recent Developments Table 43. Janssen Pharmaceuticals Company Information Table 44. Janssen Pharmaceuticals Business Overview Table 45. Janssen Pharmaceuticals Topiramate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. Janssen Pharmaceuticals Topiramate Tablets Product Portfolio Table 47. Janssen Pharmaceuticals Recent Developments Table 48. Kyowa Pharmaceutical Company Information Table 49. Kyowa Pharmaceutical Business Overview Table 50. Kyowa Pharmaceutical Topiramate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. Kyowa Pharmaceutical Topiramate Tablets Product Portfolio Table 52. Kyowa Pharmaceutical Recent Developments Table 53. Sun Pharmaceutical Company Information Table 54. Sun Pharmaceutical Business Overview Table 55. Sun Pharmaceutical Topiramate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Sun Pharmaceutical Topiramate Tablets Product Portfolio Table 57. Sun Pharmaceutical Recent Developments Table 58. Taj Pharmaceuticals Company Information Table 59. Taj Pharmaceuticals Business Overview Table 60. Taj Pharmaceuticals Topiramate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Taj Pharmaceuticals Topiramate Tablets Product Portfolio Table 62. Taj Pharmaceuticals Recent Developments Table 63. Teva Pharmaceuticals Company Information Table 64. Teva Pharmaceuticals Business Overview Table 65. Teva Pharmaceuticals Topiramate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Teva Pharmaceuticals Topiramate Tablets Product Portfolio Table 67. Teva Pharmaceuticals Recent Developments Table 68. Unichem Laboratories Company Information Table 69. Unichem Laboratories Business Overview Table 70. Unichem Laboratories Topiramate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Unichem Laboratories Topiramate Tablets Product Portfolio Table 72. Unichem Laboratories Recent Developments Table 73. Viwit Pharmaceuticals Company Information Table 74. Viwit Pharmaceuticals Business Overview Table 75. Viwit Pharmaceuticals Topiramate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Viwit Pharmaceuticals Topiramate Tablets Product Portfolio Table 77. Viwit Pharmaceuticals Recent Developments Table 78. Zydus Pharmaceuticals Company Information Table 79. Zydus Pharmaceuticals Business Overview Table 80. Zydus Pharmaceuticals Topiramate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Zydus Pharmaceuticals Topiramate Tablets Product Portfolio Table 82. Zydus Pharmaceuticals Recent Developments Table 83. Hefei Cosource (Heyuan) Pharmaceutical Company Information Table 84. Hefei Cosource (Heyuan) Pharmaceutical Business Overview Table 85. Hefei Cosource (Heyuan) Pharmaceutical Topiramate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Hefei Cosource (Heyuan) Pharmaceutical Topiramate Tablets Product Portfolio Table 87. Hefei Cosource (Heyuan) Pharmaceutical Recent Developments Table 88. Zhejiang Huahai Pharmaceutical Company Information Table 89. Zhejiang Huahai Pharmaceutical Business Overview Table 90. Zhejiang Huahai Pharmaceutical Topiramate Tablets Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Zhejiang Huahai Pharmaceutical Topiramate Tablets Product Portfolio Table 92. Zhejiang Huahai Pharmaceutical Recent Developments Table 93. Global Topiramate Tablets Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 94. Global Topiramate Tablets Sales by Region (2021-2026) & (K Units) Table 95. Global Topiramate Tablets Sales Market Share by Region (2021-2026) Table 96. Global Topiramate Tablets Sales by Region (2027-2032) & (K Units) Table 97. Global Topiramate Tablets Sales Market Share by Region (2027-2032) Table 98. Global Topiramate Tablets Revenue by Region (2021-2026) & (US$ Million) Table 99. Global Topiramate Tablets Revenue Market Share by Region (2021-2026) Table 100. Global Topiramate Tablets Revenue by Region (2027-2032) & (US$ Million) Table 101. Global Topiramate Tablets Revenue Market Share by Region (2027-2032) Table 102. North America Topiramate Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 103. North America Topiramate Tablets Sales by Country (2021-2026) & (K Units) Table 104. North America Topiramate Tablets Sales by Country (2027-2032) & (K Units) Table 105. North America Topiramate Tablets Revenue by Country (2021-2026) & (US$ Million) Table 106. North America Topiramate Tablets Revenue by Country (2027-2032) & (US$ Million) Table 107. Europe Topiramate Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 108. Europe Topiramate Tablets Sales by Country (2021-2026) & (K Units) Table 109. Europe Topiramate Tablets Sales by Country (2027-2032) & (K Units) Table 110. Europe Topiramate Tablets Revenue by Country (2021-2026) & (US$ Million) Table 111. Europe Topiramate Tablets Revenue by Country (2027-2032) & (US$ Million) Table 112. Asia Pacific Topiramate Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 113. Asia Pacific Topiramate Tablets Sales by Country (2021-2026) & (K Units) Table 114. Asia Pacific Topiramate Tablets Sales by Country (2027-2032) & (K Units) Table 115. Asia Pacific Topiramate Tablets Revenue by Country (2021-2026) & (US$ Million) Table 116. Asia Pacific Topiramate Tablets Revenue by Country (2027-2032) & (US$ Million) Table 117. South America Topiramate Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 118. South America Topiramate Tablets Sales by Country (2021-2026) & (K Units) Table 119. South America Topiramate Tablets Sales by Country (2027-2032) & (K Units) Table 120. South America Topiramate Tablets Revenue by Country (2021-2026) & (US$ Million) Table 121. South America Topiramate Tablets Revenue by Country (2027-2032) & (US$ Million) Table 122. Middle East and Africa Topiramate Tablets Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 123. Middle East and Africa Topiramate Tablets Sales by Country (2021-2026) & (K Units) Table 124. Middle East and Africa Topiramate Tablets Sales by Country (2027-2032) & (K Units) Table 125. Middle East and Africa Topiramate Tablets Revenue by Country (2021-2026) & (US$ Million) Table 126. Middle East and Africa Topiramate Tablets Revenue by Country (2027-2032) & (US$ Million) Table 127. Global Topiramate Tablets Sales by Type (2021-2026) & (K Units) Table 128. Global Topiramate Tablets Sales by Type (2027-2032) & (K Units) Table 129. Global Topiramate Tablets Sales Market Share by Type (2021-2026) Table 130. Global Topiramate Tablets Sales Market Share by Type (2027-2032) Table 131. Global Topiramate Tablets Revenue by Type (2021-2026) & (US$ Million) Table 132. Global Topiramate Tablets Revenue by Type (2027-2032) & (US$ Million) Table 133. Global Topiramate Tablets Revenue Market Share by Type (2021-2026) Table 134. Global Topiramate Tablets Revenue Market Share by Type (2027-2032) Table 135. Global Topiramate Tablets Price by Type (2021-2026) & (US$/Unit) Table 136. Global Topiramate Tablets Price by Type (2027-2032) & (US$/Unit) Table 137. Global Topiramate Tablets Sales by Application (2021-2026) & (K Units) Table 138. Global Topiramate Tablets Sales by Application (2027-2032) & (K Units) Table 139. Global Topiramate Tablets Sales Market Share by Application (2021-2026) Table 140. Global Topiramate Tablets Sales Market Share by Application (2027-2032) Table 141. Global Topiramate Tablets Revenue by Application (2021-2026) & (US$ Million) Table 142. Global Topiramate Tablets Revenue by Application (2027-2032) & (US$ Million) Table 143. Global Topiramate Tablets Revenue Market Share by Application (2021-2026) Table 144. Global Topiramate Tablets Revenue Market Share by Application (2027-2032) Table 145. Global Topiramate Tablets Price by Application (2021-2026) & (US$/Unit) Table 146. Global Topiramate Tablets Price by Application (2027-2032) & (US$/Unit) Table 147. Key Raw Materials Table 148. Raw Materials Key Suppliers Table 149. Topiramate Tablets Distributors List Table 150. Topiramate Tablets Customers List Table 151. Topiramate Tablets Industry Trends Table 152. Topiramate Tablets Industry Drivers Table 153. Topiramate Tablets Industry Restraints Table 154. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Topiramate Tablets Product Image Figure 5. Global Topiramate Tablets Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Topiramate Tablets Market Size (2021-2032) & (US$ Million) Figure 7. Global Topiramate Tablets Sales (2021-2032) & (K Units) Figure 8. Global Topiramate Tablets Average Price (US$/Unit) & (2021-2032) Figure 9. 100mg per Tablet Product Image Figure 10. 200mg per Tablet Product Image Figure 11. 25mg per Tablet Product Image Figure 12. 50mg per Tablet Product Image Figure 13. Migraine Product Image Figure 14. Epilepsy Product Image Figure 15. Other Product Image Figure 16. Global Topiramate Tablets Revenue Share by Manufacturers in 2025 Figure 17. Global Manufacturers of Topiramate Tablets, Manufacturing Sites & Headquarters Figure 18. Global Top 5 and 10 Topiramate Tablets Players Market Share by Revenue in 2025 Figure 19. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global Topiramate Tablets Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 21. Global Topiramate Tablets Sales by Region in 2025 Figure 22. Global Topiramate Tablets Revenue by Region in 2025 Figure 23. North America Topiramate Tablets Market Size by Country in 2025 Figure 24. North America Topiramate Tablets Sales Market Share by Country (2021-2032) Figure 25. North America Topiramate Tablets Revenue Market Share by Country (2021-2032) Figure 26. United States Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 27. Canada Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 28. Mexico Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 29. Europe Topiramate Tablets Market Size by Country in 2025 Figure 30. Europe Topiramate Tablets Sales Market Share by Country (2021-2032) Figure 31. Europe Topiramate Tablets Revenue Market Share by Country (2021-2032) Figure 32. Germany Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 33. France Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 34. U.K. Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. Italy Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. Russia Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Spain Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Switzerland Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 40. Sweden Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 41. Poland Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 42. Asia Pacific Topiramate Tablets Market Size by Country in 2025 Figure 43. Asia Pacific Topiramate Tablets Sales Market Share by Country (2021-2032) Figure 44. Asia Pacific Topiramate Tablets Revenue Market Share by Country (2021-2032) Figure 45. China Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Japan Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. South Korea Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. India Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Australia Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. Taiwan Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 51. Southeast Asia Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 52. Southeast Asia Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 53. South America Topiramate Tablets Market Size by Country in 2025 Figure 54. South America Topiramate Tablets Sales Market Share by Country (2021-2032) Figure 55. South America Topiramate Tablets Revenue Market Share by Country (2021-2032) Figure 56. Brazil Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 57. Argentina Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 58. Chile Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 59. Middle East and Africa Topiramate Tablets Market Size by Country in 2025 Figure 60. Middle East and Africa Topiramate Tablets Sales Market Share by Country (2021-2032) Figure 61. Middle East and Africa Topiramate Tablets Revenue Market Share by Country (2021-2032) Figure 62. Egypt Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 63. South Africa Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 64. Israel Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 65. Türkiye Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 66. GCC Countries Topiramate Tablets Revenue Growth Rate (2021-2032) & (US$ Million) Figure 67. Global Topiramate Tablets Sales Market Share by Type (2021-2032) Figure 68. Global Topiramate Tablets Revenue Market Share by Type (2021-2032) Figure 69. Global Topiramate Tablets Price (US$/Unit) by Type (2021-2032) Figure 70. Global Topiramate Tablets Sales Market Share by Application (2021-2032) Figure 71. Global Topiramate Tablets Revenue Market Share by Application (2021-2032) Figure 72. Global Topiramate Tablets Price (US$/Unit) by Application (2021-2032) Figure 73. Topiramate Tablets Value Chain Figure 74. Topiramate Tablets Production Mode & Process Figure 75. Direct Comparison with Distribution Share Figure 76. Distributors Profiles Figure 77. Topiramate Tablets Industry Opportunities and Challenges

Scope & coverage.

Types
  • 100mg per Tablet
  • 200mg per Tablet
  • 25mg per Tablet
  • 50mg per Tablet
Applications
  • Migraine
  • Epilepsy
  • Other
Companies covered
  • Accord Healthcare
  • Ascent Pharmaceuticals
  • Aurobindo Pharma
  • Cipla
  • Glenmark Pharmaceuticals
  • Janssen Pharmaceuticals
  • Kyowa Pharmaceutical
  • Sun Pharmaceutical
  • Taj Pharmaceuticals
  • Teva Pharmaceuticals
  • Unichem Laboratories
  • Viwit Pharmaceuticals
  • Zydus Pharmaceuticals
  • Hefei Cosource (Heyuan) Pharmaceutical
  • Zhejiang Huahai Pharmaceutical

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Topiramate Tablets Market Size (2021-2032)
  4. 2.2.2 Global Topiramate Tablets Sales (2021-2032)
  5. 2.2.3 Global Topiramate Tablets Market Average Price (2021-2032)
  6. 2.3 Topiramate Tablets by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 100mg per Tablet
  9. 2.3.3 200mg per Tablet
  10. 2.3.4 25mg per Tablet
  11. 2.3.5 50mg per Tablet
  12. 2.4 Topiramate Tablets by Application
  13. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  14. 2.4.2 Migraine
  15. 2.4.3 Epilepsy
  16. 2.4.4 Other
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Topiramate Tablets Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Topiramate Tablets Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Topiramate Tablets Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Topiramate Tablets Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Topiramate Tablets Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Topiramate Tablets, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Topiramate Tablets, Product Type & Application
  8. 3.8 Global Manufacturers of Topiramate Tablets, Established Date
  9. 3.9 Global Topiramate Tablets Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Accord Healthcare
  2. 4.1.1 Accord Healthcare Company Information
  3. 4.1.2 Accord Healthcare Business Overview
  4. 4.1.3 Accord Healthcare Topiramate Tablets Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Accord Healthcare Topiramate Tablets Product Portfolio
  6. 4.1.5 Accord Healthcare Recent Developments
  7. 4.2 Ascent Pharmaceuticals
  8. 4.2.1 Ascent Pharmaceuticals Company Information
  9. 4.2.2 Ascent Pharmaceuticals Business Overview
  10. 4.2.3 Ascent Pharmaceuticals Topiramate Tablets Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Ascent Pharmaceuticals Topiramate Tablets Product Portfolio
  12. 4.2.5 Ascent Pharmaceuticals Recent Developments
  13. 4.3 Aurobindo Pharma
  14. 4.3.1 Aurobindo Pharma Company Information
  15. 4.3.2 Aurobindo Pharma Business Overview
  16. 4.3.3 Aurobindo Pharma Topiramate Tablets Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Aurobindo Pharma Topiramate Tablets Product Portfolio
  18. 4.3.5 Aurobindo Pharma Recent Developments
  19. 4.4 Cipla
  20. 4.4.1 Cipla Company Information
  21. 4.4.2 Cipla Business Overview
  22. 4.4.3 Cipla Topiramate Tablets Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Cipla Topiramate Tablets Product Portfolio
  24. 4.4.5 Cipla Recent Developments
  25. 4.5 Glenmark Pharmaceuticals
  26. 4.5.1 Glenmark Pharmaceuticals Company Information
  27. 4.5.2 Glenmark Pharmaceuticals Business Overview
  28. 4.5.3 Glenmark Pharmaceuticals Topiramate Tablets Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Glenmark Pharmaceuticals Topiramate Tablets Product Portfolio
  30. 4.5.5 Glenmark Pharmaceuticals Recent Developments
  31. 4.6 Janssen Pharmaceuticals
  32. 4.6.1 Janssen Pharmaceuticals Company Information
  33. 4.6.2 Janssen Pharmaceuticals Business Overview
  34. 4.6.3 Janssen Pharmaceuticals Topiramate Tablets Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 Janssen Pharmaceuticals Topiramate Tablets Product Portfolio
  36. 4.6.5 Janssen Pharmaceuticals Recent Developments
  37. 4.7 Kyowa Pharmaceutical
  38. 4.7.1 Kyowa Pharmaceutical Company Information
  39. 4.7.2 Kyowa Pharmaceutical Business Overview
  40. 4.7.3 Kyowa Pharmaceutical Topiramate Tablets Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 Kyowa Pharmaceutical Topiramate Tablets Product Portfolio
  42. 4.7.5 Kyowa Pharmaceutical Recent Developments
  43. 4.8 Sun Pharmaceutical
  44. 4.8.1 Sun Pharmaceutical Company Information
  45. 4.8.2 Sun Pharmaceutical Business Overview
  46. 4.8.3 Sun Pharmaceutical Topiramate Tablets Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Sun Pharmaceutical Topiramate Tablets Product Portfolio
  48. 4.8.5 Sun Pharmaceutical Recent Developments
  49. 4.9 Taj Pharmaceuticals
  50. 4.9.1 Taj Pharmaceuticals Company Information
  51. 4.9.2 Taj Pharmaceuticals Business Overview
  52. 4.9.3 Taj Pharmaceuticals Topiramate Tablets Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Taj Pharmaceuticals Topiramate Tablets Product Portfolio
  54. 4.9.5 Taj Pharmaceuticals Recent Developments
  55. 4.10 Teva Pharmaceuticals
  56. 4.10.1 Teva Pharmaceuticals Company Information
  57. 4.10.2 Teva Pharmaceuticals Business Overview
  58. 4.10.3 Teva Pharmaceuticals Topiramate Tablets Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Teva Pharmaceuticals Topiramate Tablets Product Portfolio
  60. 4.10.5 Teva Pharmaceuticals Recent Developments
  61. 4.11 Unichem Laboratories
  62. 4.11.1 Unichem Laboratories Company Information
  63. 4.11.2 Unichem Laboratories Business Overview
  64. 4.11.3 Unichem Laboratories Topiramate Tablets Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Unichem Laboratories Topiramate Tablets Product Portfolio
  66. 4.11.5 Unichem Laboratories Recent Developments
  67. 4.12 Viwit Pharmaceuticals
  68. 4.12.1 Viwit Pharmaceuticals Company Information
  69. 4.12.2 Viwit Pharmaceuticals Business Overview
  70. 4.12.3 Viwit Pharmaceuticals Topiramate Tablets Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Viwit Pharmaceuticals Topiramate Tablets Product Portfolio
  72. 4.12.5 Viwit Pharmaceuticals Recent Developments
  73. 4.13 Zydus Pharmaceuticals
  74. 4.13.1 Zydus Pharmaceuticals Company Information
  75. 4.13.2 Zydus Pharmaceuticals Business Overview
  76. 4.13.3 Zydus Pharmaceuticals Topiramate Tablets Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Zydus Pharmaceuticals Topiramate Tablets Product Portfolio
  78. 4.13.5 Zydus Pharmaceuticals Recent Developments
  79. 4.14 Hefei Cosource (Heyuan) Pharmaceutical
  80. 4.14.1 Hefei Cosource (Heyuan) Pharmaceutical Company Information
  81. 4.14.2 Hefei Cosource (Heyuan) Pharmaceutical Business Overview
  82. 4.14.3 Hefei Cosource (Heyuan) Pharmaceutical Topiramate Tablets Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Hefei Cosource (Heyuan) Pharmaceutical Topiramate Tablets Product Portfolio
  84. 4.14.5 Hefei Cosource (Heyuan) Pharmaceutical Recent Developments
  85. 4.15 Zhejiang Huahai Pharmaceutical
  86. 4.15.1 Zhejiang Huahai Pharmaceutical Company Information
  87. 4.15.2 Zhejiang Huahai Pharmaceutical Business Overview
  88. 4.15.3 Zhejiang Huahai Pharmaceutical Topiramate Tablets Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Zhejiang Huahai Pharmaceutical Topiramate Tablets Product Portfolio
  90. 4.15.5 Zhejiang Huahai Pharmaceutical Recent Developments
5 Global Topiramate Tablets Market Scenario by Region
  1. 5.1 Global Topiramate Tablets Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Topiramate Tablets Sales by Region: 2021-2032
  3. 5.2.1 Global Topiramate Tablets Sales by Region: 2021-2026
  4. 5.2.2 Global Topiramate Tablets Sales by Region: 2027-2032
  5. 5.3 Global Topiramate Tablets Revenue by Region: 2021-2032
  6. 5.3.1 Global Topiramate Tablets Revenue by Region: 2021-2026
  7. 5.3.2 Global Topiramate Tablets Revenue by Region: 2027-2032
  8. 5.4 North America Topiramate Tablets Market Facts & Figures by Country
  9. 5.4.1 North America Topiramate Tablets Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Topiramate Tablets Sales by Country (2021-2032)
  11. 5.4.3 North America Topiramate Tablets Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.4.6 Mexico
  15. 5.5 Europe Topiramate Tablets Market Facts & Figures by Country
  16. 5.5.1 Europe Topiramate Tablets Market Size by Country: 2021 VS 2025 VS 2032
  17. 5.5.2 Europe Topiramate Tablets Sales by Country (2021-2032)
  18. 5.5.3 Europe Topiramate Tablets Revenue by Country (2021-2032)
  19. 5.5.4 Germany
  20. 5.5.5 France
  21. 5.5.6 U.K.
  22. 5.5.7 Italy
  23. 5.5.8 Russia
  24. 5.5.9 Spain
  25. 5.5.10 Netherlands
  26. 5.5.11 Switzerland
  27. 5.5.12 Sweden
  28. 5.5.13 Poland
  29. 5.6 Asia Pacific Topiramate Tablets Market Facts & Figures by Country
  30. 5.6.1 Asia Pacific Topiramate Tablets Market Size by Country: 2021 VS 2025 VS 2032
  31. 5.6.2 Asia Pacific Topiramate Tablets Sales by Country (2021-2032)
  32. 5.6.3 Asia Pacific Topiramate Tablets Revenue by Country (2021-2032)
  33. 5.6.4 China
  34. 5.6.5 Japan
  35. 5.6.6 South Korea
  36. 5.6.7 India
  37. 5.6.8 Australia
  38. 5.6.9 Taiwan
  39. 5.6.10 Southeast Asia
  40. 5.7 South America Topiramate Tablets Market Facts & Figures by Country
  41. 5.7.1 South America Topiramate Tablets Market Size by Country: 2021 VS 2025 VS 2032
  42. 5.7.2 South America Topiramate Tablets Sales by Country (2021-2032)
  43. 5.7.3 South America Topiramate Tablets Revenue by Country (2021-2032)
  44. 5.7.4 Brazil
  45. 5.7.5 Argentina
  46. 5.7.6 Chile
  47. 5.8 Middle East and Africa Topiramate Tablets Market Facts & Figures by Country
  48. 5.8.1 Middle East and Africa Topiramate Tablets Market Size by Country: 2021 VS 2025 VS 2032
  49. 5.8.2 Middle East and Africa Topiramate Tablets Sales by Country (2021-2032)
  50. 5.8.3 Middle East and Africa Topiramate Tablets Revenue by Country (2021-2032)
  51. 5.8.4 Egypt
  52. 5.8.5 South Africa
  53. 5.8.6 Israel
  54. 5.8.7 Türkiye
  55. 5.8.8 GCC Countries
6 Segment by Type
  1. 6.1 Global Topiramate Tablets Sales by Type (2021-2032)
  2. 6.1.1 Global Topiramate Tablets Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Topiramate Tablets Sales Market Share by Type (2021-2032)
  4. 6.2 Global Topiramate Tablets Revenue by Type (2021-2032)
  5. 6.2.1 Global Topiramate Tablets Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Topiramate Tablets Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Topiramate Tablets Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Topiramate Tablets Sales by Application (2021-2032)
  2. 7.1.1 Global Topiramate Tablets Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Topiramate Tablets Sales Market Share by Application (2021-2032)
  4. 7.2 Global Topiramate Tablets Revenue by Application (2021-2032)
  5. 7.2.1 Global Topiramate Tablets Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Topiramate Tablets Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Topiramate Tablets Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Topiramate Tablets Value Chain Analysis
  2. 8.1.1 Topiramate Tablets Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Topiramate Tablets Production Mode & Process
  5. 8.2 Topiramate Tablets Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Topiramate Tablets Distributors
  8. 8.2.3 Topiramate Tablets Customers
9 Global Topiramate Tablets Analyzing Market Dynamics
  1. 9.1 Topiramate Tablets Industry Trends
  2. 9.2 Topiramate Tablets Industry Drivers
  3. 9.3 Topiramate Tablets Industry Opportunities and Challenges
  4. 9.4 Topiramate Tablets Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst